Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Filleron

Showing results (61-70 of 199) with videos related to

Pageof 20
Sort By:
BMC Medical Research Methodology|March 2, 2025
Addressing challenges with Matching-Adjusted Indirect Comparisons to demonstrate the comparative effectiveness of entrectinib in metastatic ROS-1 positive Non-Small Cell Lung CancerCyril Esnault, Louise Baschet, Vanessa Barbet, et al.
Histopathology|October 15, 2013
Instant-quality fluorescence in-situ hybridization as a new tool for HER2 testing in breast cancer: a comparative studyCamille Franchet, Thomas Filleron, Anne Cayre, et al.
BJU International|January 21, 2015
Intermediate analysis of a phase II trial assessing gemcitabine and cisplatin in locoregional or metastatic penile squamous cell carcinomaNadine Houédé, Laura Dupuy, Aude Fléchon, et al.
Investigational New Drugs|May 9, 2020
Modernizing adverse events analysis in oncology clinical trials using alternative approaches: rationale and design of the MOTIVATE trialBastien Cabarrou, Carlos Gomez-Roca, Marie Viala, et al.
Journal of Geriatric Oncology|January 19, 2023
Enrolment of older adults with advanced or metastatic non-small cell lung cancer in first-line clinical trials in the multicentre ESME cohortMichael Bringuier, Matthieu Carton, Didier Debieuvre, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|April 21, 2021
Functional and oncological outcomes of salvage transoral robotic surgery: a comparative studyPierre Gazda, Clément Gauche, Léonor Chaltiel, et al.
European Urology Oncology|October 8, 2023
Surgery with or Without Darolutamide in High-risk and/or Locally Advanced Prostate Cancer: The SUGAR (CCAFU-PR2) Phase 2 Trial Rationale and ProtocolGiorgio Calleris, Thomas Filleron, Claudia Kesch, et al.
Breast Cancer Research and Treatment|May 11, 2017
Methodology of phase II clinical trials in metastatic elderly breast cancer: a literature reviewB Cabarrou, L Mourey, F Dalenc, et al.
BMC Cancer|August 16, 2019
Prognostic role of CD4 T-cell depletion after frontline fludarabine, cyclophosphamide and rituximab in chronic lymphocytic leukaemiaMartin Gauthier, Françoise Durrieu, Elodie Martin, et al.
Journal of Nuclear Medicine Technology|April 26, 2019
Gated <sup>18</sup>F-FDG PET/CT of the Lung Using a Respiratory Spirometric Gating Device: A Feasibility StudyCyril Jaudet, Thomas Filleron, Kathleen Weyts, et al.
Pageof 20

Showing results (61-70 of 199) with videos related to

Sort By:
Pageof 20
BMC Medical Research Methodology|March 2, 2025
Addressing challenges with Matching-Adjusted Indirect Comparisons to demonstrate the comparative effectiveness of entrectinib in metastatic ROS-1 positive Non-Small Cell Lung CancerCyril Esnault, Louise Baschet, Vanessa Barbet, et al.
Histopathology|October 15, 2013
Instant-quality fluorescence in-situ hybridization as a new tool for HER2 testing in breast cancer: a comparative studyCamille Franchet, Thomas Filleron, Anne Cayre, et al.
BJU International|January 21, 2015
Intermediate analysis of a phase II trial assessing gemcitabine and cisplatin in locoregional or metastatic penile squamous cell carcinomaNadine Houédé, Laura Dupuy, Aude Fléchon, et al.
Investigational New Drugs|May 9, 2020
Modernizing adverse events analysis in oncology clinical trials using alternative approaches: rationale and design of the MOTIVATE trialBastien Cabarrou, Carlos Gomez-Roca, Marie Viala, et al.
Journal of Geriatric Oncology|January 19, 2023
Enrolment of older adults with advanced or metastatic non-small cell lung cancer in first-line clinical trials in the multicentre ESME cohortMichael Bringuier, Matthieu Carton, Didier Debieuvre, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|April 21, 2021
Functional and oncological outcomes of salvage transoral robotic surgery: a comparative studyPierre Gazda, Clément Gauche, Léonor Chaltiel, et al.
European Urology Oncology|October 8, 2023
Surgery with or Without Darolutamide in High-risk and/or Locally Advanced Prostate Cancer: The SUGAR (CCAFU-PR2) Phase 2 Trial Rationale and ProtocolGiorgio Calleris, Thomas Filleron, Claudia Kesch, et al.
Breast Cancer Research and Treatment|May 11, 2017
Methodology of phase II clinical trials in metastatic elderly breast cancer: a literature reviewB Cabarrou, L Mourey, F Dalenc, et al.
BMC Cancer|August 16, 2019
Prognostic role of CD4 T-cell depletion after frontline fludarabine, cyclophosphamide and rituximab in chronic lymphocytic leukaemiaMartin Gauthier, Françoise Durrieu, Elodie Martin, et al.
Journal of Nuclear Medicine Technology|April 26, 2019
Gated <sup>18</sup>F-FDG PET/CT of the Lung Using a Respiratory Spirometric Gating Device: A Feasibility StudyCyril Jaudet, Thomas Filleron, Kathleen Weyts, et al.
Pageof 20